Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dingsheng Liu

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Hematology (Amsterdam, Netherlands)|September 19, 2022
Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myelomaXiaojia Zuo, Dingsheng Liu
Oncotargets and Therapy|December 9, 2021
Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach AdenocarcinomaNing Wang, Dingsheng Liu
European Journal of Medical Research|August 31, 2022
Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinomaLili Guo, Dingsheng Liu
Alimentary Pharmacology & Therapeutics|April 25, 2025
Letter: Re-Examining Seton Efficacy in Perianal Crohn's Disease-Considerations for Outcome Measurement and Clinical InterpretationDingsheng Liu, Banghua Zhong, Lili Guo
Biomicrofluidics|February 25, 2016
An automated microfluidic system for screening Caenorhabditis elegans behaviors using electrotaxisDingsheng Liu, Bhagwati Gupta, Ponnambalam Ravi Selvaganapathy
Cancer Medicine|April 10, 2021
miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2Dingsheng Liu, Chunsheng Chen, Mingming Cui, et al.
American Journal of Translational Research|October 12, 2020
Identification of immune checkpoint inhibitors and biomarkers among STAT family in stomach adenocarcinomaLili Guo, Te Fang, Yanhua Jiang, et al.
International Journal of General Medicine|December 23, 2021
IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach AdenocarcinomaLili Guo, Te Fang, Yanhua Jiang, et al.
Nutrition and Cancer|July 11, 2025
Ketogenic Diets Are Associated with an Elevated Risk for All Cancers: Insights from a Cross-Sectional Analysis of the NHANES 2001-2018Yuping Liu, Xiaolong Qu, Dingsheng Liu, et al.
International Immunopharmacology|August 17, 2023
SYVN1 attenuates ferroptosis and alleviates spinal cord ischemia-reperfusion injury in rats by regulating the HMGB1/NRF2/HO-1 axisLili Guo, Dong Zhang, Xiaoyan Ren, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Hematology (Amsterdam, Netherlands)|September 19, 2022
Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myelomaXiaojia Zuo, Dingsheng Liu
Oncotargets and Therapy|December 9, 2021
Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach AdenocarcinomaNing Wang, Dingsheng Liu
European Journal of Medical Research|August 31, 2022
Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinomaLili Guo, Dingsheng Liu
Alimentary Pharmacology & Therapeutics|April 25, 2025
Letter: Re-Examining Seton Efficacy in Perianal Crohn's Disease-Considerations for Outcome Measurement and Clinical InterpretationDingsheng Liu, Banghua Zhong, Lili Guo
Biomicrofluidics|February 25, 2016
An automated microfluidic system for screening Caenorhabditis elegans behaviors using electrotaxisDingsheng Liu, Bhagwati Gupta, Ponnambalam Ravi Selvaganapathy
Cancer Medicine|April 10, 2021
miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2Dingsheng Liu, Chunsheng Chen, Mingming Cui, et al.
American Journal of Translational Research|October 12, 2020
Identification of immune checkpoint inhibitors and biomarkers among STAT family in stomach adenocarcinomaLili Guo, Te Fang, Yanhua Jiang, et al.
International Journal of General Medicine|December 23, 2021
IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach AdenocarcinomaLili Guo, Te Fang, Yanhua Jiang, et al.
Nutrition and Cancer|July 11, 2025
Ketogenic Diets Are Associated with an Elevated Risk for All Cancers: Insights from a Cross-Sectional Analysis of the NHANES 2001-2018Yuping Liu, Xiaolong Qu, Dingsheng Liu, et al.
International Immunopharmacology|August 17, 2023
SYVN1 attenuates ferroptosis and alleviates spinal cord ischemia-reperfusion injury in rats by regulating the HMGB1/NRF2/HO-1 axisLili Guo, Dong Zhang, Xiaoyan Ren, et al.
Pageof 4